Roles for IL-1 and TNFα in dynamic behavioral responses of Langerhans cells to topical hapten application

Journal of Dermatological Science

Volumn 45, Issue 1, 2007, Pages 23-30

  Nishibu, Akiko ^a   Ward, Brant R ^a   Boes, Marianne ^b   Takashima, Akira ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cytokines; Imaging; Langerhans cells

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; CYTOKINE RECEPTOR ANTAGONIST; ENHANCED GREEN FLUORESCENT PROTEIN; HAPTEN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ARTICLE; CELL FUNCTION; CELL MIGRATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; KERATINOCYTE; KNOCKOUT MOUSE; LANGERHANS CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADMINISTRATION, TOPICAL; ANIMALS; CELL MOVEMENT; DINITROFLUOROBENZENE; DRUG SYNERGISM; FLUORESCENT DYES; GREEN FLUORESCENT PROTEINS; HAPTENS; HISTOCOMPATIBILITY ANTIGENS CLASS II; INJECTIONS, SUBCUTANEOUS; INTERLEUKIN-1ALPHA; KINETICS; LANGERHANS CELLS; MICE; MICE, TRANSGENIC; RECOMBINANT PROTEINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845720294     PISSN: 09231811     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2006.10.003     Document Type: Article

References (29)

1. Clark R., and Kupper T. Old meets new: the interaction between innate and adaptive immunity. J Invest Dermatol 125 (2005) 629-637
2. Braff M.H., Bardan A., Nizet V., and Gallo R.L. Cutaneous defense mechanisms by antimicrobial peptides. J Invest Dermatol 125 (2005) 9-13
3. Banchereau J., and Steinman R.M. Dendritic cells and the control of immunity. Nature 392 (1998) 245-252
4. Larrengina A.T., and Falo L.D. Changing paradigms in cutaneous immunology: adapting with dendritic cells. J Invest Dermatol 124 (2005) 1-12
5. Romani N., Holzmann S., Tripp C.H., Koch F., and Stoitzner P. Langerhans cells-dendritic cells of the epidermis. Apmis 111 (2003) 725-740
6. Steinman R.M., and Nussenzweig M.C. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 99 (2002) 351-358
7. Aiba S., and Katz S.I. Phenotypic and functional characteristics of in vivo-activated Langerhans cells. J Immunol 145 (1990) 2791-2796
8. + dendritic cells but not by Langerhans cells. Science 301 (2003) 1925-1928
9. Ritter U., Meissner A., Scheidig C., and Korner H. CD8α- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis. Eur J Immunol 34 (2004) 1542-1550
10. Zhao X., Deak E., Soderberg K., Linehan M., Spezzano D., Zhu J., et al. Vaginal submucosal dendritic cells, but not Langerhans cells, induce protective Th1 responses to herpes simplex virus-2. J Exp Med 197 (2003) 153-162
11. Bennett C.L., van Rijn E., Jung S., Inaba K., Steinman R.M., Kapsenberg M.L., et al. Inducible ablation of mouse Langerhans cells diminishes but fails to abrogate contact hypersensitivity. J Cell Biol 169 (2005) 569-576
12. Kissenpfennig A., Henri S., Dubois B., et al. Dynamics and function of Langerhans cells in vivo dermal dendritic cells colonize lymph node areas distinct from slower migrating Langerhans cells. Immunity 22 (2005) 643-654
13. Kaplan D.H., Jenison M.C., Saeland S., Shlomchik W.D., and Shlomchik M.J. Epidermal langerhans cell-deficient mice develop enhanced contact hypersensitivity. Immunity 23 (2005) 611-620
14. Cumberbatch M., Dearman R.J., and Kimber I. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration. Immunology 92 (1997) 388-395
15. Love-Schimenti C.D., and Kripke M.L. Dendritic epidermal T cells inhibit T cell proliferation and may induce tolerance by cytotoxicity. J Immunol 153 (1994) 3450-3456
16. Stoitzner P., Holzmann S., McLellan A.D., et al. Visualization and characterization of migratory Langerhans cells in murine skin and lymph nodes by antibodies against Langerin/CD207. J Invest Dermatol 120 (2003) 266-274
17. Stoitzner P., Tripp C.H., Douillard P., Saeland S., and Romani N. Migratory langerhans cells in mouse lymph nodes in steady state and inflammation. J Invest Dermatol 125 (2005) 116-125
18. Boes M., Cerny J., Massol R., Op D.B., Kirchhausen T., Chen J., et al. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418 (2002) 983-988
19. Nishibu A., Ward B.R., Jester J.V., Ploegh H.L., Boes M., and Takashima A. Behavioral responses of epidermal Langerhans cells in situ to local pathological stimuli. J Invest Dermatol 126 (2006) 787-796
20. Vishwanath M., Nishibu A., Saeland S., Ward B.R., Mizumoto N., Ploegh H.L., et al. Development of intravital intermittent confocal imaging system for studying langerhans cell turnover. J Invest Dermatol 126 (2006) 2452-2457
21. Enk A.H., and Katz S.I. Early molecular events in the induction phase of contact sensitivity. Proc Natl Acad Sci USA 89 (1992) 1398-1402
22. Wang B., Zhuang L., Fujisawa H., et al. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 162 (1999) 277-283
23. Homey B., Assmann T., Vohr H.W., Ulrich P., Lauerma A.I., Ruzicka T., et al. Topical FK506 suppresses cytokine and costimulatory molecule expression in epidermal and local draining lymph node cells during primary skin immune responses. J Immunol 160 (1998) 5331-5340
24. Cumberbatch M., Fielding I., and Kimber I. Modulation of epidermal Langerhans' cell frequency by tumour necrosis factor-α. Immunology 81 (1994) 395-401
25. Cumberbatch M., Dearman R.J., and Kimber I. Interleukin 1β and the stimulation of Langerhans cell migration: comparisons with tumour necrosis factor α. Arch Dermatol Res 289 (1997) 277-284
26. Stoitzner P., Zanella M., Ortner U., et al. Migration of Langerhans cells and dermal dendritic cells in skin organ cultures: augmentation by TNF-α and IL-1β. J Leuk Biol 66 (1999) 462-470
27. Jakob T., Ring J., and Udey M.C. Multistep navigation of Langerhans/dendritic cells in and out of the skin. J Allergy Clin Immunol 108 (2001) 688-696
28. Leonardi C.L., Powers J.L., Matheson R.T., et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 349 (2003) 2014-2022
29. Gottlieb A.B., Chamian F., Masud S., Cardinale I., Abello M.V., Lowes M.A., et al. TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques. J Immunol 175 (2005) 2721-2729